Copyright Reports & Markets. All rights reserved.

Global Drugs for Ophthalmology Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Drugs for Ophthalmology Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Drugs for Ophthalmology Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Drugs for Ophthalmology Market Size Growth Rate by Type
    • 1.4.2 Gels
    • 1.4.3 Eye Solutions
    • 1.4.4 Capsules & Tablets
    • 1.4.5 Eye Drops
    • 1.4.6 Ointments
  • 1.5 Market by Application
    • 1.5.1 Global Drugs for Ophthalmology Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Retail Pharmacy
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Drugs for Ophthalmology Market Size, Estimates and Forecasts
    • 2.1.1 Global Drugs for Ophthalmology Revenue 2015-2026
    • 2.1.2 Global Drugs for Ophthalmology Sales 2015-2026
  • 2.2 Global Drugs for Ophthalmology, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Drugs for Ophthalmology Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Drugs for Ophthalmology Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Drugs for Ophthalmology Competitor Landscape by Players

  • 3.1 Drugs for Ophthalmology Sales by Manufacturers
    • 3.1.1 Drugs for Ophthalmology Sales by Manufacturers (2015-2020)
    • 3.1.2 Drugs for Ophthalmology Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Drugs for Ophthalmology Revenue by Manufacturers
    • 3.2.1 Drugs for Ophthalmology Revenue by Manufacturers (2015-2020)
    • 3.2.2 Drugs for Ophthalmology Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Drugs for Ophthalmology Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Drugs for Ophthalmology Revenue in 2019
    • 3.2.5 Global Drugs for Ophthalmology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Drugs for Ophthalmology Price by Manufacturers
  • 3.4 Drugs for Ophthalmology Manufacturing Base Distribution, Product Types
    • 3.4.1 Drugs for Ophthalmology Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Drugs for Ophthalmology Product Type
    • 3.4.3 Date of International Manufacturers Enter into Drugs for Ophthalmology Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Drugs for Ophthalmology Market Size by Type (2015-2020)
    • 4.1.1 Global Drugs for Ophthalmology Sales by Type (2015-2020)
    • 4.1.2 Global Drugs for Ophthalmology Revenue by Type (2015-2020)
    • 4.1.3 Drugs for Ophthalmology Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Drugs for Ophthalmology Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Drugs for Ophthalmology Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Drugs for Ophthalmology Revenue Forecast by Type (2021-2026)
    • 4.2.3 Drugs for Ophthalmology Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Drugs for Ophthalmology Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Drugs for Ophthalmology Market Size by Application (2015-2020)
    • 5.1.1 Global Drugs for Ophthalmology Sales by Application (2015-2020)
    • 5.1.2 Global Drugs for Ophthalmology Revenue by Application (2015-2020)
    • 5.1.3 Drugs for Ophthalmology Price by Application (2015-2020)
  • 5.2 Drugs for Ophthalmology Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Drugs for Ophthalmology Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Drugs for Ophthalmology Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Drugs for Ophthalmology Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Drugs for Ophthalmology by Country
    • 6.1.1 North America Drugs for Ophthalmology Sales by Country
    • 6.1.2 North America Drugs for Ophthalmology Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Drugs for Ophthalmology Market Facts & Figures by Type
  • 6.3 North America Drugs for Ophthalmology Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Drugs for Ophthalmology by Country
    • 7.1.1 Europe Drugs for Ophthalmology Sales by Country
    • 7.1.2 Europe Drugs for Ophthalmology Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Drugs for Ophthalmology Market Facts & Figures by Type
  • 7.3 Europe Drugs for Ophthalmology Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Drugs for Ophthalmology by Region
    • 8.1.1 Asia Pacific Drugs for Ophthalmology Sales by Region
    • 8.1.2 Asia Pacific Drugs for Ophthalmology Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Drugs for Ophthalmology Market Facts & Figures by Type
  • 8.3 Asia Pacific Drugs for Ophthalmology Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Drugs for Ophthalmology by Country
    • 9.1.1 Latin America Drugs for Ophthalmology Sales by Country
    • 9.1.2 Latin America Drugs for Ophthalmology Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Drugs for Ophthalmology Market Facts & Figures by Type
  • 9.3 Central & South America Drugs for Ophthalmology Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Drugs for Ophthalmology by Country
    • 10.1.1 Middle East and Africa Drugs for Ophthalmology Sales by Country
    • 10.1.2 Middle East and Africa Drugs for Ophthalmology Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Drugs for Ophthalmology Market Facts & Figures by Type
  • 10.3 Middle East and Africa Drugs for Ophthalmology Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Allergan
    • 11.1.1 Allergan Corporation Information
    • 11.1.2 Allergan Description and Business Overview
    • 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Allergan Drugs for Ophthalmology Products Offered
    • 11.1.5 Allergan Related Developments
  • 11.2 Aerie Pharmaceuticals
    • 11.2.1 Aerie Pharmaceuticals Corporation Information
    • 11.2.2 Aerie Pharmaceuticals Description and Business Overview
    • 11.2.3 Aerie Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Aerie Pharmaceuticals Drugs for Ophthalmology Products Offered
    • 11.2.5 Aerie Pharmaceuticals Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description and Business Overview
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Drugs for Ophthalmology Products Offered
    • 11.3.5 Pfizer Related Developments
  • 11.4 Valeant
    • 11.4.1 Valeant Corporation Information
    • 11.4.2 Valeant Description and Business Overview
    • 11.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Valeant Drugs for Ophthalmology Products Offered
    • 11.4.5 Valeant Related Developments
  • 11.5 Bayer
    • 11.5.1 Bayer Corporation Information
    • 11.5.2 Bayer Description and Business Overview
    • 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bayer Drugs for Ophthalmology Products Offered
    • 11.5.5 Bayer Related Developments
  • 11.6 Genentech
    • 11.6.1 Genentech Corporation Information
    • 11.6.2 Genentech Description and Business Overview
    • 11.6.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Genentech Drugs for Ophthalmology Products Offered
    • 11.6.5 Genentech Related Developments
  • 11.7 Novartis
    • 11.7.1 Novartis Corporation Information
    • 11.7.2 Novartis Description and Business Overview
    • 11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Novartis Drugs for Ophthalmology Products Offered
    • 11.7.5 Novartis Related Developments
  • 11.8 Regeneron
    • 11.8.1 Regeneron Corporation Information
    • 11.8.2 Regeneron Description and Business Overview
    • 11.8.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Regeneron Drugs for Ophthalmology Products Offered
    • 11.8.5 Regeneron Related Developments
  • 11.9 Takeda
    • 11.9.1 Takeda Corporation Information
    • 11.9.2 Takeda Description and Business Overview
    • 11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Takeda Drugs for Ophthalmology Products Offered
    • 11.9.5 Takeda Related Developments
  • 11.10 Santen Pharmaceutical
    • 11.10.1 Santen Pharmaceutical Corporation Information
    • 11.10.2 Santen Pharmaceutical Description and Business Overview
    • 11.10.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Santen Pharmaceutical Drugs for Ophthalmology Products Offered
    • 11.10.5 Santen Pharmaceutical Related Developments
  • 11.1 Allergan
    • 11.1.1 Allergan Corporation Information
    • 11.1.2 Allergan Description and Business Overview
    • 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Allergan Drugs for Ophthalmology Products Offered
    • 11.1.5 Allergan Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Drugs for Ophthalmology Market Estimates and Projections by Region
    • 12.1.1 Global Drugs for Ophthalmology Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Drugs for Ophthalmology Revenue Forecast by Regions 2021-2026
  • 12.2 North America Drugs for Ophthalmology Market Size Forecast (2021-2026)
    • 12.2.1 North America: Drugs for Ophthalmology Sales Forecast (2021-2026)
    • 12.2.2 North America: Drugs for Ophthalmology Revenue Forecast (2021-2026)
    • 12.2.3 North America: Drugs for Ophthalmology Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Drugs for Ophthalmology Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Drugs for Ophthalmology Sales Forecast (2021-2026)
    • 12.3.2 Europe: Drugs for Ophthalmology Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Drugs for Ophthalmology Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Drugs for Ophthalmology Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Drugs for Ophthalmology Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Drugs for Ophthalmology Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Drugs for Ophthalmology Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Drugs for Ophthalmology Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Drugs for Ophthalmology Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Drugs for Ophthalmology Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Drugs for Ophthalmology Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Drugs for Ophthalmology Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Drugs for Ophthalmology Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Drugs for Ophthalmology Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Drugs for Ophthalmology Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Drugs for Ophthalmology Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Drugs for Ophthalmology Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Drugs for Ophthalmology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Ophthalmology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Drugs for Ophthalmology market is segmented into
    Gels
    Eye Solutions
    Capsules & Tablets
    Eye Drops
    Ointments

    Segment by Application, the Drugs for Ophthalmology market is segmented into
    Hospital
    Retail Pharmacy

    Regional and Country-level Analysis
    The Drugs for Ophthalmology market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Drugs for Ophthalmology market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Drugs for Ophthalmology Market Share Analysis
    Drugs for Ophthalmology market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drugs for Ophthalmology business, the date to enter into the Drugs for Ophthalmology market, Drugs for Ophthalmology product introduction, recent developments, etc.

    The major vendors covered:
    Allergan
    Aerie Pharmaceuticals
    Pfizer
    Valeant
    Bayer
    Genentech
    Novartis
    Regeneron
    Takeda
    Santen Pharmaceutical

    Buy now